Stay updated on IMmotion151: Atezo + Bev vs Sunitinib in Untreated Adv RCC Clinical Trial
Sign up to get notified when there's something new on the IMmotion151: Atezo + Bev vs Sunitinib in Untreated Adv RCC Clinical Trial page.

Latest updates to the IMmotion151: Atezo + Bev vs Sunitinib in Untreated Adv RCC Clinical Trial page
- Check6 days agoChange DetectedThe footer revision label changes from v3.7.2 to v3.8.0, indicating a website software update.SummaryDifference0.0%

- Check13 days agoChange DetectedA site-wide NIH banner announces that federal agencies are using “Super Intelligence” in place of “Artificial Intelligence” during a transition.SummaryDifference0.3%

- Check20 days agoChange DetectedThe site footer now identifies the page as running revision v3.7.2 instead of v3.7.1.SummaryDifference0.0%

- Check27 days agoChange DetectedThe ClinicalTrials.gov page’s footer revision identifier was updated from v3.7.0 to v3.7.1.SummaryDifference0.0%

- Check48 days agoChange DetectedA new revision entry labeled v3.7.0 has been added to the history, replacing the previous v3.6.6 entry. This reflects an update to the page's underlying system or content management without changing visible core content.SummaryDifference0.0%

- Check70 days agoChange DetectedA new revision tag, v3.6.6, was added and the previous tag, v3.6.5, removed in the page's version history, indicating a small site update.SummaryDifference0.0%

Stay in the know with updates to IMmotion151: Atezo + Bev vs Sunitinib in Untreated Adv RCC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the IMmotion151: Atezo + Bev vs Sunitinib in Untreated Adv RCC Clinical Trial page.